Literature DB >> 2550675

Guanidine-resistant mutants of poliovirus have distinct mutations in peptide 2C.

R F Baltera1, D R Tershak.   

Abstract

In previous work in our laboratory, 12 guanidine-resistant (gr) mutants of poliovirus were selected from 12 separate stocks of plaque-purified guanidine-sensitive (gs) viruses (K. Anderson-Sillman, S. Bartal, and D. R. Tershak, J. Virol. 50:922-928, 1984). Peptide mapping of protein 2C and evaluation of virus growth at different temperatures enabled us to subdivide these mutants into several distinct groups (D. R. Tershak, Can. J. Microbiol. 31:1166-1168, 1985; Anderson-Sillman et al., J. Virol.). Studies by Pincus et al. indicate that two nucleotide changes in codon 179 of protein 2C leads to an Asn-to-Gly or Asn-to-Ala change and that these missense modifications account for guanidine resistance (S. E. Pincus, H. Rohl, and E. Wimmer, Virology 157:83-88, 1987; S. E. Pincus and E. Wimmer, J. Virol. 60:793-796, 1986). In the present report, we confirm their findings but also show that a single amino acid change of Phe to Tyr in residue 164 of protein 2C or a Met-to-Leu replacement in amino acid 187 coupled with mutations in codons 233 or 295 and 309 could confer guanidine resistance.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550675      PMCID: PMC251066          DOI: 10.1128/JVI.63.10.4441-4444.1989

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  In vitro inhibition of infectivity of polio viruses by guanidine.

Authors:  B LODDO; W FERRARI; G BROTZU; A SPANEDDA
Journal:  Nature       Date:  1962-01-06       Impact factor: 49.962

2.  Initiation of polyribosome formation in poliovirus-infected HeLa cells.

Authors:  A S Huang; D Balitmore
Journal:  J Mol Biol       Date:  1970-02-14       Impact factor: 5.469

3.  Recombinants of Mahoney and Sabin strain poliovirus type 1: analysis of in vitro phenotypic markers and evidence that resistance to guanidine maps in the nonstructural proteins.

Authors:  E A Emini; J Leibowitz; D C Diamond; J Bonin; E Wimmer
Journal:  Virology       Date:  1984-08       Impact factor: 3.616

4.  Systematic nomenclature of picornavirus proteins.

Authors:  R R Rueckert; E Wimmer
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

5.  Production of guanidine-resistant and -dependent poliovirus mutants from cloned cDNA: mutations in polypeptide 2C are directly responsible for altered guanidine sensitivity.

Authors:  S E Pincus; E Wimmer
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

6.  Effect of temperature on growth of guanidine-resistant mutants of poliovirus.

Authors:  D R Tershak
Journal:  Can J Microbiol       Date:  1985-12       Impact factor: 2.419

7.  Guanidine-selected mutants of poliovirus: mapping of point mutations to polypeptide 2C.

Authors:  S E Pincus; D C Diamond; E A Emini; E Wimmer
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

8.  Guanidine-resistant poliovirus mutants produce modified 37-kilodalton proteins.

Authors:  K Anderson-Sillman; S Bartal; D R Tershak
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

9.  Inhibition of poliovirus polymerase by guanidine in vitro.

Authors:  D R Tershak
Journal:  J Virol       Date:  1982-01       Impact factor: 5.103

10.  Guanidine-resistant mutants of aphthovirus induce the synthesis of an altered nonstructural polypeptide, P34.

Authors:  K Saunders; A M King
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

View more
  28 in total

1.  Initiation of poliovirus negative-strand RNA synthesis requires precursor forms of p2 proteins.

Authors:  Christy Jurgens; James B Flanegan
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Synchronous replication of poliovirus RNA: initiation of negative-strand RNA synthesis requires the guanidine-inhibited activity of protein 2C.

Authors:  D J Barton; J B Flanegan
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Poliovirus 2C region functions during encapsidation of viral RNA.

Authors:  L M Vance; N Moscufo; M Chow; B A Heinz
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population.

Authors:  Marco Vignuzzi; Jeffrey K Stone; Jamie J Arnold; Craig E Cameron; Raul Andino
Journal:  Nature       Date:  2005-12-04       Impact factor: 49.962

5.  Identification of regions of poliovirus 2BC protein that are involved in cytotoxicity.

Authors:  A Barco; L Carrasco
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  A C-terminal, cysteine-rich site in poliovirus 2C(ATPase) is required for morphogenesis.

Authors:  Chunling Wang; Hsin-Chieh Ma; Eckard Wimmer; Ping Jiang; Aniko V Paul
Journal:  J Gen Virol       Date:  2014-02-20       Impact factor: 3.891

Review 7.  Emergency Services of Viral RNAs: Repair and Remodeling.

Authors:  Vadim I Agol; Anatoly P Gmyl
Journal:  Microbiol Mol Biol Rev       Date:  2018-03-14       Impact factor: 11.056

8.  Poliovirus protein 3AB forms a complex with and stimulates the activity of the viral RNA polymerase, 3Dpol.

Authors:  S J Plotch; O Palant
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Poliovirus 5'-terminal cloverleaf RNA is required in cis for VPg uridylylation and the initiation of negative-strand RNA synthesis.

Authors:  T Lyons; K E Murray; A W Roberts; D J Barton
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  The thiazolobenzimidazole TBZE-029 inhibits enterovirus replication by targeting a short region immediately downstream from motif C in the nonstructural protein 2C.

Authors:  Armando M De Palma; Ward Heggermont; Kjerstin Lanke; Bruno Coutard; Mirko Bergmann; Anna-Maria Monforte; Bruno Canard; Erik De Clercq; Alba Chimirri; Gerhard Pürstinger; Jacques Rohayem; Frank van Kuppeveld; Johan Neyts
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.